Cátedra UNESCO de Bioética

Contacto

 

"The world’s first CRISPR therapy is approved: who will receive it?"

Nature

The go-ahead for Vertex’s gene editing therapy in sickle cell disease and β-thalassemia is a historic milestone, but this one-time treatment is costly.